GleamWall
中文EN

DXCM DEXCOM INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1093557 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.0%
TTM net income YoY37.5%
TTM EPS YoY41.1%
Revenue 3-yr CAGR14.5%
Net income 3-yr CAGR38.0%

Margins

Gross margin63.4%
Operating margin24.0%
Net margin19.4%
FCF margin21.5%
EBITDA margin29.4%

Returns

ROE37.7%
ROA14.4%
ROIC (approx.)78.0%
Asset turnover0.74x

Leverage & solvency

Liabilities / assets59.4%
Debt / equity0.00x
Current ratio1.74x
Interest coverage91.33x

Cash quality & payout

Operating cash flow / net income1.43x
Accruals ratio-6.2%
Payout ratio—
Capex / revenue6.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$4.66B$4.03B
Cost of revenue$1.86B$1.59B
Gross profit$2.80B$2.44B
R&D expense$599.10M$552.40M
SG&A expense$1.29B$1.29B
Operating income$911.80M$600.00M
Interest expense$18.30M$19.00M
Pretax income$1.09B$709.00M
Income tax$252.10M$132.80M
Net income$836.30M$576.20M
EBITDA$1.16B$817.70M
EPS (basic)2.141.46
EPS (diluted)2.091.42
Weighted avg. shares (diluted)405.50M412.70M
Balance sheet
Cash & equivalents$917.70M$607.30M
Short-term investments—$1.73B
Receivables$1.22B$1.01B
Inventory$629.10M$542.60M
Current assets$4.03B$4.30B
PP&E, net$1.56B$1.34B
Goodwill$24.20M$22.80M
Intangibles$70.80M$103.40M
Total assets$6.34B$6.48B
Current liabilities$2.14B$2.93B
Total liabilities$3.59B$4.38B
Shareholders' equity$2.75B$2.10B
Shares outstanding384.80M390.70M
Cash flow statement
Operating cash flow$1.44B$989.50M
Capital expenditure$363.50M$358.80M
Free cash flow$1.08B$630.70M
Investing cash flow$536.00M-$207.50M
Financing cash flow-$1.69B-$734.80M
Depreciation & amortization$251.80M$217.70M
Stock-based compensation$159.60M$170.40M
Share buybacks$500.00M$750.00M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.